432 related articles for article (PubMed ID: 22460183)
1. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial.
Locatelli F; Pozzi C; Del Vecchio L; Andrulli S; Pani A; Fogazzi G; Altieri P; Ponticelli C
J Nephrol; 1999; 12(5):308-11. PubMed ID: 10630693
[TBL] [Abstract][Full Text] [Related]
4. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of IgA nephropathy with chronic renal failure].
Pozzi C
G Ital Nefrol; 2008; 25 Suppl 44():83-7. PubMed ID: 19048591
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.
Manno C; Gesualdo L; D'Altri C; Rossini M; Grandaliano G; Schena FP
J Nephrol; 2001; 14(4):248-52. PubMed ID: 11506246
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY
Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine.
Stangou M; Papagianni A; Bantis C; Moisiadis D; Kasimatis S; Spartalis M; Pantzaki A; Efstratiadis G; Memmos D
Clin Nephrol; 2013 Sep; 80(3):203-10. PubMed ID: 23611517
[TBL] [Abstract][Full Text] [Related]
10. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
[TBL] [Abstract][Full Text] [Related]
11. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
[TBL] [Abstract][Full Text] [Related]
12. Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.
Pozzi C; Andrulli S; Pani A; Scaini P; Del Vecchio L; Fogazzi G; Vogt B; De Cristofaro V; Allegri L; Cirami L; Procaccini AD; Locatelli F
J Am Soc Nephrol; 2010 Oct; 21(10):1783-90. PubMed ID: 20634300
[TBL] [Abstract][Full Text] [Related]
13. Can immunosuppressive drugs slow the progression of IgA nephropathy?
Goumenos D; Ahuja M; Shortland JR; Brown CB
Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
[TBL] [Abstract][Full Text] [Related]
14. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
Maixnerova D; Bauerova L; Skibova J; Rysava R; Reiterova J; Merta M; Honsova E; Tesar V
Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
16. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.
Eitner F; Ackermann D; Hilgers RD; Floege J
J Nephrol; 2008; 21(3):284-9. PubMed ID: 18587715
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T
Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
Kanno Y; Okada H; Saruta T; Suzuki H
Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
[TBL] [Abstract][Full Text] [Related]
19. Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients.
Ohya M; Otani H; Minami Y; Yamanaka S; Mima T; Negi S; Yukawa S; Shigematsu T
Clin Nephrol; 2013 Jul; 80(1):47-52. PubMed ID: 23557791
[TBL] [Abstract][Full Text] [Related]
20. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]